Barbara Belli
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Infectious Diseases top 5%
- Viral gastroenteritis research and epidemiology
- Viral Infections and Outbreaks Research
Papers in
-
- RNA Interference and Gene Delivery 4
- Genetics 8
- Chronic Lymphocytic Leukemia Research 8
- Virus-based gene therapy research 5
- Co-authors
- Thomas W. Dubensky (7 shared papers)John M. Polo (7 shared papers)David A. Driver (7 shared papers)Robert C. Armstrong (9 shared papers)Ruwanthi N. Gunawardane (3 shared papers)Silvia Perri (4 shared papers)Daniel Brigham (6 shared papers)Shripad S. Bhagwat (5 shared papers)
- Journals
- Journal of Virology (7 papers)Blood (4 papers)Virology (3 papers)Cancer Research (3 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Barbara Belli
26 papers receiving 1.2k citations
Barbara Belli's Hit Papers
Peers
Comparison fields: 5 of 66
- Hematology 401
- Infectious Diseases 355
- Virology 86
- Genetics 177
- Immunology 283
Countries citing papers authored by Barbara Belli
This map shows the geographic impact of Barbara Belli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Belli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Belli more than expected).
Fields of papers citing papers by Barbara Belli
This network shows the impact of papers produced by Barbara Belli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Belli. The network helps show where Barbara Belli may publish in the future.
Co-authors
The 25 scholars most cited alongside Barbara Belli, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML) Hit paper breakdown → | 2009 | 479 |
| 2 | 1996 | 155 | |
| 3 | 1998 | 145 | |
| 4 | 1999 | 109 | |
| 5 | 2000 | 100 | |
| 6 | 2000 | 99 | |
| 7 | 2013 | 39 | |
| 8 | Alphavirus DNA and particle replicons for vaccines and gene therapy. | 2000 | 37 |
| 9 | 1991 | 24 | |
| 10 | 1995 | 19 | |
| 11 | 2015 | 17 | |
| 12 | 1994 | 16 | |
| 13 | 1995 | 14 | |
| 14 | 1995 | 14 | |
| 15 | 2011 | 13 | |
| 16 | 2012 | 10 | |
| 17 | 1993 | 10 | |
| 18 | 2019 | 9 | |
| 19 | 1995 | 8 | |
| 20 | Early (preleukemic) events in Moloney murine leukemia virus leukemogenesis. | 1997 | 4 |
About Barbara Belli
Barbara Belli is a scholar working on Molecular Biology, Genetics, Hematology, Immunology and Infectious Diseases, having authored 28 papers that have together received 1.3k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (8 papers), Acute Myeloid Leukemia Research (7 papers), Virus-based gene therapy research (5 papers), RNA Interference and Gene Delivery (4 papers), Chronic Myeloid Leukemia Treatments (4 papers), Microtubule and mitosis dynamics (3 papers), interferon and immune responses (3 papers) and Viral Infections and Outbreaks Research (3 papers). The work is most often cited by research in Hematology (401 citations), Infectious Diseases (355 citations), Virology (86 citations), Genetics (177 citations) and Immunology (283 citations). Barbara Belli has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Thomas W. Dubensky, John M. Polo, David A. Driver, Robert C. Armstrong, Ruwanthi N. Gunawardane, Silvia Perri, Daniel Brigham, Shripad S. Bhagwat, Michael F. Gardner and Patrick P. Zarrinkar. Their work appears in journals such as Journal of Virology, Blood, Virology, Cancer Research and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.